6-methyl-1,3,8-trichlorodibenzofuran has been researched along with beta-naphthoflavone in 1 studies
Studies (6-methyl-1,3,8-trichlorodibenzofuran) | Trials (6-methyl-1,3,8-trichlorodibenzofuran) | Recent Studies (post-2010) (6-methyl-1,3,8-trichlorodibenzofuran) | Studies (beta-naphthoflavone) | Trials (beta-naphthoflavone) | Recent Studies (post-2010) (beta-naphthoflavone) |
---|---|---|---|---|---|
25 | 0 | 3 | 1,238 | 0 | 147 |
Protein | Taxonomy | 6-methyl-1,3,8-trichlorodibenzofuran (IC50) | beta-naphthoflavone (IC50) |
---|---|---|---|
Cytochrome P450 1A1 | Homo sapiens (human) | 0.054 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.2767 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.5149 | |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | 5.4667 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 7.185 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ballarotto, M; Dolciami, D; Fallarino, F; Gargaro, M; López-Cara, LC; Macchiarulo, A | 1 |
1 review(s) available for 6-methyl-1,3,8-trichlorodibenzofuran and beta-naphthoflavone
Article | Year |
---|---|
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).
Topics: Animals; Humans; Immune System Diseases; Immunotherapy; Ligands; Molecular Structure; Receptors, Aryl Hydrocarbon | 2020 |